Infection and Immunosuppression as Causes for Immune Dysfunction Presenting as Hemophagocytic Lymphohistiocytosis and Thrombotic Microangiopathy
DOI:
https://doi.org/10.20344/amp.21969Keywords:
Lymphohistiocytosis, Hemophagocytic/etiologyAbstract
N/A
Downloads
References
McClain KL, Eckstein O. Clinical features and diagnosis of hemophagocytic lymphohistiocytosis. May 2022. UpToDate. [cited 2024 June 15]. Available from: https://www.uptodate.com/contents/clinical-features-and-diagnosis-of-hemophagocyticlymphohistiocytosis?search=hemophagocytic%20lymphohistiocytosis&source=search_result&selectedTitle=1%7E150&usage_type=default&display_rank=1.
McGonagle D, Sharif K, O’Regan A, Bridgewood C. The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease. autoimmunity reviews. Autoimmun Rev. 2020;19:102537.
Meazza Prina M, Martini F, Bracchi F, Di Mauro D, Fargnoli A, Motta M, et al. Hemophagocytic syndrome secondary to SARS-Cov-2 infection: a case report. BMC Infect Dis. 2021;21:811.
Soy M, Atagündüz P, Atagündüz I, Sucak GT. Hemophagocytic lymphohistiocytosis: a review inspired by the COVID-19 pandemic. Rheumatol Int. 2021;41:7-18.
Singh S, Murad MH, Fumery M, Sedano R, Jairath V, Panaccione R, et al. Comparative efficacy and safety of biologic therapies for moderateto- severe crohn’s disease: a systematic review and network metaanalysis. Lancet Gastroenterol Hepatol. 2021;6:1002-14.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Acta Médica Portuguesa
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
All the articles published in the AMP are open access and comply with the requirements of funding agencies or academic institutions. The AMP is governed by the terms of the Creative Commons ‘Attribution – Non-Commercial Use - (CC-BY-NC)’ license, regarding the use by third parties.
It is the author’s responsibility to obtain approval for the reproduction of figures, tables, etc. from other publications.
Upon acceptance of an article for publication, the authors will be asked to complete the ICMJE “Copyright Liability and Copyright Sharing Statement “(http://www.actamedicaportuguesa.com/info/AMP-NormasPublicacao.pdf) and the “Declaration of Potential Conflicts of Interest” (http:// www.icmje.org/conflicts-of-interest). An e-mail will be sent to the corresponding author to acknowledge receipt of the manuscript.
After publication, the authors are authorised to make their articles available in repositories of their institutions of origin, as long as they always mention where they were published and according to the Creative Commons license.